Paul Johnson & Oliver Friesen from Power Metal presented at London South East's September Webinar. Watch the full presentation here.
Good evening all.
It appears some shareholders are have the attack of the “Julys”!
When we were waiting for Phase2 Hospital trials it was so tough. Many people sold early July. They were complaining that the company should be issuing more RNS’s and that a Richard and the PR should be more high profile.
I have learnt over the last 12 months is is not the Synairgen way. The team are following strict protocol. The data has to be 100% to receive Lancet approval. Overlay the NDA’s which are undoubtedly now in place and there simply is no wriggle room.
If you believe in the drug.... and boy there is so much positive research into Interferon.... I think you will want Synairgen to take their time on the data.
We know if the data was poor Synairgen would fail fast. We have not received that RNS.
Yes it is frustrating watching the Auto Trades pin down the price. I topped up this week in the high 160’s !!
However I believe, like most here believe, that we are invested in that ultra special company which have discovered (over the last 16 years) an amazing life changing drug.
Not long to wait now !!!
Nassimi’s post is a prime example of what I was saying earlier. Subtle de ramping and playing with your mind
Challenge the trolls they will simply call you a ramper.
The virus will disappear from this board soon. We have SNG001 which is a broad Spectrum Anti Viral.... strong enough to take down any troll !
Valid question or misleading statement ???
I think genuine holders that have invested time and money understanding the importance of Interferon, both through many many independent trials and also Synairgen’s own trials.
Those wanting news to push the share price to where it was last week and those wanting the CEO to appear in a video to boost the share price (ramp the company) clearly don’t understand Richard Marsden.
“This is an investment not a quick day trade” not my words, words of RM early last year. On Aim this share is quite unusual in the fact it is an investment. Those who bought in the March placing did see an excellent return in July. I expect those that bought at 175p will see a similar ROI later this year.
With is company “data is king” and “it’s all about the end game”.
The issue with this board is it can be infected with day traders and shorters that try and mislead and scare investors into selling.
A subtle statement of doubt say Interferon would only last during dosing is a prime example. Sweeping statement based on zero data.
I highly recommend genuine holder to join one of the closed groups on social media. LSE doesn’t offer this service, hence why it is full of trolls (most shares have there resident de rampers).
Will another day closer to results for Synairgen.
“14 day course unlikely to have long lasting effect”
Really where is the data for this statement ?
I’m sorry why would Synairgen spend time investigating LONG COVID if there was no “Long” lasting effect.
Some patients with health issues might only receive “in use benefit” and require long term treatment. However sweeping statements like the one below are simply misleading.
I know some doubt my statement that the company has had data from HT for 8 days. The company is allowed to spend time analysing the data. They might also choose to ask for an expert opinion prior to publishing.... this could be the FDA !
Back in July data was rushed out, which resulted in a clean up RNS having to be published. I know the team will want to ensure this mistake doesn’t happen twice. That is why they are taking their time.
With the share price 10p below placing, for me this offers amazing value. I will be adding a few more today.
As always Best of British to genuine holders.
Please don’t expect any Tweet from Richard Marsden or any member of the team.
They are under the strictest confidentiality agreements and also must follow FCA regulations.
The company received the Phase2 HT data on Wednesday.
We will be updated. Soon.
Good luck genuine holders !
I think some people might want to understand the meaning of the words above.
Anyone trying to suggest SNG is only a Covid play is under researched.
What about other viral infections. What about our BioBank, What about LOXL2, what about pre orders.....
I am no expert in Mutations, but if what I’m seeing in New York is replicated, Covid19 is here to stay. Therapeutics will become increasingly important and May one day be more important than vaccines.
I take it people like Happy who are mainly invested in oil will head back to their share chatrooms and no longer post here.
As for Synairgen's shareholders , wow we are in for a fun few weeks !!!
I am coming up to my 12 month anniversary with Synairgen.
It was the 18th March when Synairgen announced they had first approval to trial SNG001 covid19 trials.
Synairgen then quickly raised funds at 35p to fund the trial.
Before that the company had been hit hard by Woodford and the business was in bad shape.
So with cash to fund the hospital Phase2 trials Synairgen expedited trials across the U.K. As the trials went on shareholders watched Richard Griffiths sell down from +14% holding. Then we had Link fund sell down from +17% even Lansdowne were selling. This was a tough time for all holders. Probably the most challenging time was early July, when yet another fund cleared their holding, this time Acacia Research sold the shares they acquired from Woodford. At this point this board was full of speculation, trolls and negativity. It was a tough time to hold even when the science looked promising.
Well we are now approaching our next major set of results. Holding over the last 6 months has been much easier for me. The science around Interferon is so strong now. Hearing Sir Stephen being so confident on Sky News was the icing on the cake.
So as we approach our next major news, as we approach the anniversary of the first Phase2 announcement (tomorrow) and as I approach my holding anniversary, I personally wish every genuine holder here the best of luck.
I believe Synairgen is a once in 10 year stock. I believe SNG001 will change the fight against C19 and other viral infections for the next 25 years.
I’m proud to be a shareholder here and look forward to the weeks ahead.
I’m so excited about the next two weeks. We all know what is coming.
A member of the Guild, Telegram and Reddit closed groups. The quality of research in the groups is outstanding. The positive and negatives are debated and we feel like a close family. I would highly recommend joining one or all.
I won’t say how, as if you are keen to join you will find a way.
This board is full of meme’s that drown out the quality posts. It’s such a shame LSE can’t control the multi account holders.
As mentioned at the start, the U.K. home data will be cleansed by now and number crunchers will be reaching their conclusions. Activ2 will also be close to filling Phase2 and we know Phase3 will is progressing well with new countries about to join the trial.
Good luck all genuine holders !
Goods news from GSK, however MABS are expensive and require the patent to visit a clinic. There is the potential for a Mutation to reduce the efficacy level of MABS. I believe this has already been flagged in a different study.
Overall good news for our fight against covid19.
As for SNG, bring on the data !!
We remain in an ultra strong position with our broad spectrum anti viral!!
Mr Personality must have a very lonely life posting his highly undervalued opinion on here day in day out.
Clearly he is not invested, which is a real shame for him as he will miss out in all the excitement which is about to land.
What will be first ?
TR1 or Year End financials ?
Then Home Trials and Activ2.
Phase3 is also recruiting well.
“Any half serious investor” OMG what a statement.
Everyone knows LSE chatroom is a joke. We only post on here to play with the trolls. Most SNG investors are in locked groups which keep the likes of Scinv and his multiple login friends out.
It’s a shame but very true.
Syn00gold. It appears this board is being dominated by a troll who has already been proven wrong numerous times.
You are correct we are very close to the end game now.
I believe loyal shareholders will be rewarded. Back in June this board was full of trolls and then July landed, where are they now ??
IMO same thing will happen next month. They will be dust !
Some very strange posts on this chatroom over the last week.
It’s clear Activ2 is progressing and either the design of this trial medics and professors will be seeing real time results.
This is the first time Synairgen management and trial organisers will have real time data. This is mega exciting.
We also have the Home trial data. It should be cleansed about now. I have no doubt this data will be shared with the FDA at the earliest possibility.
The Phase3 hospital trials remain ongoing. I have 200% confidence that Paralex are firing on all cylinders.
This is a crucial month for Synairgen data gather. April will then be the month of data release.
I really expect FOMO to kick in by Friday. As leaks will happen in the US. We are already seeing Twitter chatter about SNG from some highly regarded medics.
Oooo exciting times !!
Good luck all.
Sir Stephen confirmed it works and is safe.
Investors are now starting to wake up to just how special this company could be.
It’s not often in your lifespan of investing that you get an opportunity to invest in a company with the potential of Synairgen.
As I have said already. If Synairgen was listed in America it would already be valued at over $billion.
March will be one exciting month. April has the potential to change allot of people’s lives for the better.
I will counter my positivity with a warning that something could go wrong, however the significant amount of positive independent research outside of Synairgen combined with the amazing team at Synairgen, gives me ultra confidence in my investment.
FOMO will kick in this month. Good luck all.
Trytosmile our thoughts are with you and the family.
This Virus is cruel and left the world in shock.
Let’s hope strong treatments and vaccines continue to be developed in the years ahead. Take care and raise a whisky to your good friend this evening.